|Epigenetic regulation of CXCR4 expression by the ocular microenvironment.|
|PMID: 23188729 Owner: NLM Status: MEDLINE|
|PURPOSE: Expression of the chemokine receptor CXCR4 by tumors is associated with metastatic migration and invasion of tumor cells. The importance of CXCR4 expression by uveal melanomas in metastasis to the liver was recently demonstrated when injection of CXCR4-negative uveal melanoma cells into mice resulted in reduced liver metastasis compared with CXCR4-positive uveal melanoma cells. Factors in the eye can induce downregulation of genes by epigenetic mechanisms. This study examined whether epigenetic regulation by the ocular environment induced downregulation of CXCR4 expression.
METHODS: LS174T colon cancer cells were injected in the anterior chamber (AC), subcutaneously (SC), or in the spleen capsule to induce liver metastasis in immune-deficient mice. CXCR4 gene transcription was analyzed by RT-PCR, and protein expression was determined by flow cytometry. Methyltransferase and histone deacetylase activities were determined by ELISA. Treatment with either 5-Aza-2-deoxycytidine (5-Aza) or trichostatin A (TSA) was used to induce demethylation or inhibit histone deacetylases, respectively.
RESULTS: AC-derived LS174T cells showed lower CXCR4 gene expression compared with SC-, liver-derived, or wild-type tumor cells. AC-derived LS174T tumor cells expressed methyltransferase activity compared with SC-, liver-derived, and wild-type tumor cells. Deacetylase activity was elevated in AC-derived LS174T tumor cells compared with SC-derived, liver-derived, and wild-type tumor cells. Treatment of AC-derived LS174T tumor cells with 5-Aza upregulated CXCR4 expression. TSA treatment did not restore CXCR4 expression.
CONCLUSIONS: These studies demonstrate that ocular microenvironment factors induce methylation and downregulation of tumor CXCR4 expression.
|Haochuan Li; Jerry Y Niederkorn; Leila Sadegh; Jessamee Mellon; Peter W Chen|
Related Documents :
|21253819 - Biomechanical forces shape the tumor microenvironment.
15812359 - A novel approach to tumor suppression using microencapsulated engineered j558/tnf-alpha...
1899559 - Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide.
23836039 - Aberrant expression of notch3 predicts poor survival for hepatocellular carcinomas.
15148449 - Amniotic fluid tumor necrosis factor-alpha is a marker for the prediction of early-onse...
24836949 - Imaging of hepatocellular carcinoma patient-derived xenografts using (89)zr-labeled ant...
16476779 - The tumor suppressor dapk inhibits cell motility by blocking the integrin-mediated pola...
12149419 - H1(0) histone and differentiation of dendritic cells. a molecular target for tumor-deri...
7641689 - Persistent epstein-barr virus infection in a human t-cell line: unique program of laten...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2013-01-09|
|Title: Investigative ophthalmology & visual science Volume: 54 ISSN: 1552-5783 ISO Abbreviation: Invest. Ophthalmol. Vis. Sci. Publication Date: 2013 Jan|
|Created Date: 2013-01-10 Completed Date: 2013-03-12 Revised Date: 2013-10-30|
Medline Journal Info:
|Nlm Unique ID: 7703701 Medline TA: Invest Ophthalmol Vis Sci Country: United States|
|Languages: eng Pagination: 234-43 Citation Subset: IM|
|Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9057, USA.|
|APA/MLA Format Download EndNote Download BibTex|
Anterior Chamber / metabolism*, pathology
Antimetabolites, Antineoplastic / pharmacology
Azacitidine / analogs & derivatives, pharmacology
Cecum / metabolism, pathology
Cell Line, Tumor
Gene Expression Regulation, Neoplastic / physiology
Histone Deacetylase Inhibitors / administration & dosage
Histone Deacetylases / metabolism
Histones / metabolism
Hydroxamic Acids / administration & dosage
Lysine / metabolism
Mice, Inbred BALB C
Promoter Regions, Genetic
Receptors, CXCR4 / drug effects, genetics*, metabolism*
Reverse Transcriptase Polymerase Chain Reaction
Spleen / metabolism, pathology
|CA30276/CA/NCI NIH HHS; EY017198/EY/NEI NIH HHS; EY020799/EY/NEI NIH HHS; R01 CA030276/CA/NCI NIH HHS|
|0/Antimetabolites, Antineoplastic; 0/CXCR4 protein, mouse; 0/Histone Deacetylase Inhibitors; 0/Histones; 0/Hydroxamic Acids; 0/Receptors, CXCR4; 320-67-2/Azacitidine; 3X2S926L3Z/trichostatin A; 56-87-1/Lysine; 776B62CQ27/decitabine; EC 22.214.171.124/Histone Deacetylases|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The pupillary response to color and luminance variant multifocal stimuli.
Next Document: Independent passive mechanical behavior of bovine extraocular muscle compartments.